早期瘤囊缩小是日本患者腹主动脉瘤腔内修复术后持久成功的良好替代标志物
基于日本多中心数据库的回顾性分析纳入697例2008至2015年行EVAR并随访至少1年的腹主动脉瘤患者,早期瘤囊缩小(术后1年内直径缩小>5 mm)发生率为48.1%,与晚期并发症风险降低独立相关(校正HR 0.425,P=.004),而I型内漏和孤立性II型内漏与晚期并发症风险升高正相关。
要点
- 早期瘤囊缩小(1年内直径缩小>5 mm)发生率为48.1%,与晚期并发症风险降低独立相关(校正HR 0.425)。
- I型内漏和孤立性II型内漏与晚期并发症正相关(校正HR分别为11.774和5.137,均P<.001)。
- I型内漏和孤立性II型内漏与早期瘤囊缩小负相关(校正OR分别为0.102和0.285,均P<.001)。
核心结论
- 早期瘤囊缩小与亚洲人群EVAR术后晚期并发症低风险相关,可能是EVAR术后持久成功的良好替代标志物。
- I型内漏和孤立性II型内漏与早期瘤囊缩小负相关、与晚期并发症正相关。
- 鉴于孤立性II型内漏发生率高,II型内漏可能是亚洲人群EVAR术后需考虑的重要情况。
研究设计与样本
- 回顾性分析日本多中心数据库2008至2015年行腹主动脉瘤EVAR并随访至少1年的697例患者。
- 晚期并发症定义为EVAR术后>1年发生的任何动脉瘤相关事件,包括瘤囊直径增大>5 mm及任何再次干预。
- 无瘤囊增大证据或无需额外治疗的内漏不视为晚期并发症。
主要发现
- 早期瘤囊缩小(EVAR术后1年内直径缩小>5 mm)发生于335例患者(48.1%)。
- I型内漏发生率为4.0%,孤立性II型内漏(无其他内漏证据的II型内漏)发生率为29.4%。
- 平均随访45.5个月期间发生93例晚期并发症(13.3%)。
- Kaplan-Meier曲线和log-rank分析显示早期瘤囊缩小是晚期并发症低风险的显著预测因素(P<.001)。
- 多因素分析显示早期瘤囊缩小与晚期并发症低风险独立相关(校正HR 0.425,P=.004);I型内漏和孤立性II型内漏与晚期并发症正相关(校正HR分别为11.774和5.137,均P<.001);I型内漏和孤立性II型内漏与早期瘤囊缩小负相关(校正OR分别为0.102和0.285,均P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The applicability of early sac shrinkage as a predictor of a low risk of late complications after endovascular aneurysm repair (EVAR) in Asian populations has not been validated. This study aimed to analyze early sac shrinkage and its relationship with late complications in Asian people using a Japanese multicenter database. We also assessed the impact of endoleaks. METHODS: A retrospective analysis of 697 patients who had undergone EVAR of abdominal aortic aneurysms from 2008 to 2015 and were followed up for at least 1 year was conducted. Late complications were defined as any aneurysm-related events occurring >1 year after EVAR, including >5-mm aneurysm sac enlargements and any reinterventions performed. Endoleaks without any evidence of sac enlargement or a requirement for additional treatment were not considered late complications. RESULTS: Early sac shrinkage, defined as a >5-mm-diameter decrease within 1 year of EVAR, occurred in 335 patients (48.1%); type I endoleaks (T1ELs) and isolated type II endoleaks (iT2ELs; type II endoleaks without evidence of other endoleaks) were observed in 4.0% and 29.4%, respectively. During the mean follow-up period of 45.5 months, 93 late complications (13.3%) occurred. Kaplan-Meier curve and log-rank analyses showed that early sac shrinkage was a significant predictor for a lower risk of late complications (P < .001). Multivariate analysis revealed that early sac shrinkage was independently associated with a lower risk of late complications (adjusted hazard ratio, 0.425; P = .004). Conversely, T1ELs and iT2ELs were positively associated with late complication (adjusted hazard ratio, 11.774 and 5.137, respectively; both P < .001). Subsequent multivariate analysis demonstrated that T1ELs and iT2ELs were negatively associated with early sac shrinkage (adjusted odds ratio, 0.102 and 0.285, respectively; both P < .001). CONCLUSIONS: Early sac shrinkage was associated with a low risk of late complications in Asian people and may be a good surrogate marker of durable success after EVAR. T1ELs and iT2ELs were negatively associated with early sac shrinkage and positively associated with late complications. Along with the high incidence of iT2ELs observed, T2ELs may be an important condition to consider after EVAR in the Asian population.
引用
- Fujimura N, Matsubara K, Takahara M, et al. Early sac shrinkage is a good surrogate marker of durable success after endovascular aneurysm repair in Japanese patients. J Vasc Surg. 2018. PMID: 29685249. doi:10.1016/j.jvs.2017.08.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。